drug

MT-101

Phase 1updated 3mo ago

by MThera Pharma Co Ltd

Phase 1

community read0 votes

indications

Parkinson's Disease

all catalysts(0)

nothing on the calendar yet

Trials studying MT-101

phase2A Study of MT-101 in Subjects With CD5+ Relapsed/Refractory TCLsuspendedn=40

News(0)

no news has mentioned this drug yet

Data sources

ClinicalTrials.gov

last refreshed 40m ago

Found something off?

comments(0)

5-min edit window · permanent after that

no comments yet — first sniff?

drug

save

MT-101

Phase 1updated 3mo ago

by MThera Pharma Co Ltd

Phase 1

community read0 votes

indications

Parkinson's Disease

all catalysts(0)

nothing on the calendar yet

Trials studying MT-101

phase2A Study of MT-101 in Subjects With CD5+ Relapsed/Refractory TCLsuspendedn=40

News(0)

no news has mentioned this drug yet

Data sources

ClinicalTrials.gov

last refreshed 40m ago

Found something off?

comments(0)

5-min edit window · permanent after that

no comments yet — first sniff?

MT-101

indications

all catalysts(0)

Trials studying MT-101

News(0)

Report a data issue

comments(0)

MT-101

indications

all catalysts(0)

Trials studying MT-101

News(0)

Report a data issue

comments(0)